Australia markets close in 5 hours 25 minutes

Genmab A/S (GMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
36.27-0.17 (-0.47%)
At close: 04:00PM EDT
36.27 0.00 (0.00%)
After hours: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close36.44
Open36.57
Bid35.88 x 900
Ask36.25 x 800
Day's range36.20 - 36.71
52-week range26.19 - 49.07
Volume367,553
Avg. volume649,801
Market cap23.685B
Beta (5Y monthly)0.64
PE ratio (TTM)43.18
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

    Company Announcement COPENHAGEN, Denmark; August 17, 2022 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) made by managerial employees and their closely associated persons. The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to publish trading

  • GlobeNewswire

    Capital Increase in Genmab as a Result of Employee Warrant Exercise

    Company Announcement COPENHAGEN, Denmark; August 16, 2022 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 46,441 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the company or others. The shares are subscribed in cash at the following price per share of nominally DKK 1: 2,750 shares at DKK 636.50,762 shares at DKK 815.50,6,513 shares at DKK 939.50,17,463 shares at DKK 1,025.00,8,3

  • GlobeNewswire

    Transactions in connection with share buy-back program

    Company Announcement COPENHAGEN, Denmark; August 15, 2022 – Genmab A/S (Nasdaq: GMAB). On June 17, 2022 Genmab announced the initiation of a share buy-back program to mitigate dilution from warrant exercises and to honor our commitments under our Restricted Stock Units program. The share buy-back program is expected to be completed no later than August 31, 2022 and comprises up to 370,000 shares. The following transactions were executed under the program from August 8, 2022 to August 12, 2022: N